Indeed, higher serum prolactin levels seem to be related to higher BC risk in postmenopausal women under hormone replacement therapy (HRT), not showing an effect in non-HRT users and even showing an inverse non-significant association in pre-menopausal women [68]. The gene discussed is PRL; the disease is breast cancer.